๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
COSCIENS Biopharma Inc. (TSX:CSCI)
Canada flag Canada ยท Delayed Price ยท Currency is CAD
8.25
-0.35 (-4.07%)
Nov 19, 2026, 11:10 AM EST

COSCIENS Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
9.767.59.597.1414.575.26
Revenue Growth
13.35%-21.79%34.22%-50.98%177.03%44.03%
Gross Profit
4.812.574.732.948.565.17
Operating Income
-5.47-10.44-9.94-4.634.32-8.67
Net Income
4.93-10.36-15.31-3.493.45-8.37
Earnings Per Share
4.72-9.82-17.79-5.675.58-21.84
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Active Ingredient
7.048.497.1414.57-
Biopharmaceutical
0.461.1--5.26
Total
7.59.597.1414.575.26

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.217.3116.396.6850.6165.3
Total Debt
14.092.152.311.70.180.16
Net Cash (Debt)
-4.885.1614.084.9850.4365.14
Net Cash Growth
--63.37%182.79%-90.13%-22.58%170.43%
Net Cash Per Share
-4.074.8916.378.0981.58170.04

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-1.51-8.47-14.57-2.585.23-8.58
Capital Expenditures
-0.16-0.71-1.16-0.72-0.3-0.03
Free Cash Flow
-1.67-9.18-15.73-3.34.93-8.61
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
49.32%34.29%49.33%41.13%58.71%98.29%
Operating Margin
-56.05%-139.25%-103.70%-64.81%29.65%-164.85%
Pretax Margin
-75.94%-138.01%-158.81%-61.18%31.07%-161.16%
Profit Margin
50.52%-138.14%-159.69%-48.79%23.66%-159.09%
FCF Margin
-17.14%-122.42%-164.07%-46.26%33.80%-163.71%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
1.23---4.47-
Forward PE
-0.640.640.640.640.64
P/FCF Ratio
----3.13-
PS Ratio
0.590.880.501.321.068.30